Mednet’s Post

The recent TechCrunch article highlights Healx's impressive $47 million raise to advance AI-enabled drug discovery for rare diseases. This development is a significant step forward in tackling conditions that have long been underserved. At Somite Therapeutics, we share this commitment to transforming the landscape of rare disease treatment through innovative AI solutions. Our own work is dedicated to leveraging cutting-edge technology to address unmet medical needs and drive breakthroughs in healthcare. Together with pioneers like Healx, we are advancing the frontiers of techbio. Read more about this exciting progress here. https://lnkd.in/gxwgRNXC  #AI #TechBio #RareDiseases #SomiteTherapeutics Micha Y. Breakstone 🇮🇱🎗️

Hello #ESHG2024 attendees! Come to booth #428 for one of our 5-min product demos where we showcase our latest software innovations. If you attend one of these demos, you will receive one of our famous t-shirts. 10:10 - Somatic NGS Workflow with VarSeq - Streamlining Tertiary Analysis with Oncogenicity Classifier and CancerKB 12:10 - PGx: Pharmacogenomics Workflow 12:40 - VarSeq Dx: Using the VarSeq Suite as a Medical Device Under IVDR 13:10 - Whole Genome Analysis with Long Read Data 13:40 - Carrier Status Analysis in VarSeq 15:40 - NGS Enterprise Capabilities - Automation, Warehousing, Continuous Improvement 16:40 - Calling CNV with Twist Exome 2.0 #ESHG #Genetics #NGS #PrecisionMedicine

A new white paper from ERGOMED explores the best approaches for backfilling Phase I studies to replace participants who have dropped out or failed to meet the study criteria after initial enrollment. Backfilling can keep enrollment momentum and help accumulate more data on estimated safety and efficacy. Read the white paper to uncover backfilling recommendations for various Phase I study scenarios: https://lnkd.in/dpHukxCZ #Ergomed #OncologyCRO #ClinicalResearchServices #Backfilling

Our Chief Data Officer, Ronald Chan recently shared insights of "The Omico Experience," at the "Future of Precision Medicine in Oncology: Tissue Agnostic Biomarker driven Therapies" workshop! At Omico, we have access to incredible data, RWE expertise, and a network of medical oncologists and academics ready to make a difference! 💬 Let’s connect! If you’re looking for RWE data and a dedicated partner, reach out to Chief Data Officer Ronald Chan via email at r.chan@omico.org.au. Special thanks to MAPPA-MAPS for your collaboration in advancing oncology research! #Omico #PrecisionOncology #CancerMeetsItsMatch #ComprehensiveGenomicProfiling #PrecisionMedicine #Oncology #RWE

Digital therapeutics (DTx) is still in its early stages in the Lifesciences industry, whereas many other sectors, including heavily regulated ones like banking, financial services, and insurance (BFSI), transitioned to digital solutions a decade or more ago. As Pharma embraces digital therapeutics, it's crucial to focus not only on marketing and sales strategy but also on robust data analytics to support the successful launch and ongoing success of DTx products. By incorporating insights from industries that have already navigated the digital transition, Pharma can create more effective, secure, and patient-centric digital therapeutic solutions. Be sure to join the session to learn more about how we're helping a client launch a novel digital therapeutic, exploring these strategies and best practices to ensure a successful outcome.

Don’t miss this chance to gain a comprehensive understanding of how PGT-M testing is performed in public hospitals, understand the market trends and dynamics of PGT-M testing, expand your professional connections, and participate in our live insightful discussion. #PGTtesting #PGTM #PreimplantationGeneticTesting #NGS #NextgenerationSequencing #webinar #ThermoFisherScientific #thermofisheremp

Hello clinical research scientists in my network 📣! Tyler's webinar on ELISpot and FluoroSpot in clinical trials is now available online for you to watch as many times as you wish. Link in his post below!

Simplify your genetic testing workflow! OGT has just introduced the SureSeq Myeloid Fusion Panel, an innovative NGS tool designed to consolidate various diagnostic processes into one efficient solution. 🧬 This means you get faster, more reliable results, helping you make critical decisions swiftly. The panel enables labs to streamline operations and reduce turnaround time. For healthcare professionals, this translates to quicker diagnostics and better patient management. 🌟 👉 Check out how the SureSeq Myeloid Fusion Panel can revolutionize your lab’s capabilities here: https://lnkd.in/g5_eq37M Don't forget to share this exciting news with peers who could benefit too! #GeneticTesting #LaboratoryEquipment #Diagnostics

🚀 Hybridization-based #sequencing, including whole exome sequencing, often requires a complex, time-consuming workflow that can contribute to assay variability. Download our recent poster from #ASHG2024 to learn how our new PCR-free Trinity™ workflow expands what’s possible on a benchtop platform by eliminating or integrating post-hybridization steps onboard an #AVITI system.  Not only does it save hours of hands-on time, ⏰ but it provides significant performance improvements compared to traditional workflows, including more uniform coverage, lower duplication rates, and improved benchmarking.    View the poster and discover how Trinity can transform your workflow: https://bit.ly/3Oo5NOr #ElemBio #TrinityWorkflow #Genomics

We had an amazing turnout for yesterday's Mabtech webinars on ELISpot and FluoroSpot in clinical trials! Whether you’re new to the assays or need insights for your next trial, this webinar has you covered. What we covered: - A quick dive into why ELISpot/FluoroSpot are considered the gold standard for immune monitoring. - Validation strategies to ensure data reliability and regulatory compliance. - Tips for implementing these assays in vaccine, immunotherapy, cell, and gene therapy trials. 💡 Missed it live? No problem! The full recording is now available on YouTube! Grab a coffee, hit play, and discover how to improve your assay SOPs and clinical trials with precision immune monitoring. Watch now: https://lnkd.in/d-hmiUqh Have any questions after watching? Let’s keep the conversation going in the comments or feel free to message me or our amazing panelists Renata Varnaitė, PhD and Esther Schoutrop 🚀 #ClinicalTrials #ELISpot #FluoroSpot #ImmuneMonitoring